News from delmar pharmaceuticals A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Nov 17, 2014, 08:00 ET
DelMar Pharmacokinetic Summary

DelMar Pharmaceuticals' Promising New Data Support the Potential of VAL-083 to Meet Significant Unmet Medical Needs in the Treatment of Glioblastoma Multiforme

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") today announced the presentation of new data supporting the...

Nov 14, 2014, 11:45 ET

DelMar Pharmaceuticals Presents Preclinical Data Supporting VAL-083 as a Potential New Treatment in Glioblastoma at the Society of Neuro-Oncology Annual Meeting

DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") today announced the presentation of an abstract entitled, In vivo...

Nov 10, 2014, 08:00 ET

DelMar Pharmaceuticals Announces September 30, 2014 Results and Provides Corporate Update

DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the company") today announced the filing of September 30, 2014 quarterly financial...

Nov 06, 2014, 08:00 ET

DelMar Pharmaceuticals Invited to Present New Data on VAL-083 in the Treatment of Glioblastoma Multiforme at the Society for NeuroOncology Annual Meeting

- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") today announced that the Company has been invited to present three...

Oct 09, 2014, 08:44 ET

VAL-083 Demonstrates Promise as a Potential Treatment for Non-small Cell Lung Cancer

 DelMar Pharmaceuticals, Inc., (OTCQB: DMPI), a clinical-stage oncology company, today announced the presentation of promising new data...

Oct 06, 2014, 11:47 ET

DelMar Pharmaceuticals Announces Presentations at Upcoming Scientific Meetings

DelMar Pharmaceuticals, Inc., (OTCQB: DMPI), a clinical-stage oncology company, today announced that the company has been invited to present new...

Sep 04, 2014, 08:00 ET

DelMar Pharmaceuticals to Present at the SeeThruEquity Fall Microcap Investor Conference

 DelMar Pharmaceuticals, Inc., (OTCQB: DMPI), a clinical-stage oncology company, will be featured as a presenting company at the SeeThruEquity...

Sep 03, 2014, 08:00 ET

DelMar Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent for VAL-083

DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced that the United States Patent and Trademark Office (USPTO) has issued a...

Aug 29, 2014, 08:00 ET

DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments

DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the Company") today announced the filing of June 30, 2014 fiscal year-end financial...

Aug 27, 2014, 14:57 ET

DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference

 DelMar Pharmaceuticals, Inc., (OTCQB: DMPI), developer of advanced cancer therapeutics, will be featured as a presenting company at the 16th...

Aug 19, 2014, 08:00 ET

DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the company") announced today a protocol amendment to allow for expanded dosing in its...

Jul 24, 2014, 16:07 ET

DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial

DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the company") announced today that the company's board of directors approved a change of the...

Jul 09, 2014, 08:00 ET

DelMar Pharmaceuticals Receives Funding from the Canadian Federal Government

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") announced today that the company has been awarded a non-refundable financial...

Jun 09, 2014, 07:30 ET

DelMar Pharmaceuticals, Inc. Presentation Now Available for On-Demand viewing at RetailInvestorConferences.com

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma"), a clinical-stage company advancing breakthrough cancer...

Jun 02, 2014, 16:44 ET

DelMar Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com June 5th

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma"), a clinical-stage company advancing breakthrough cancer therapeutics...

May 31, 2014, 07:30 ET

DelMar Pharmaceuticals Presents Promising VAL-083 Interim Data from GBM Clinical Trial at ASCO

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") announced the presentation of interim clinical data from the company's ongoing clinical...

May 22, 2014, 08:00 ET

DelMar Pharmaceuticals to Present at the Third Annual Marcum LLP MicroCap Conference

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma"), a clinical-stage company advancing breakthrough cancer...

May 20, 2014, 18:04 ET

DelMar Pharmaceuticals Gives Quarterly Shareholder Update

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") provided a quarterly update and a summary of progress toward the...

May 16, 2014, 08:00 ET

DelMar Pharmaceuticals Updates VAL-083 Glioblastoma Clinical Trial Progress

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") is pleased to provide an update on the company's ongoing Phase I/II clinical trial for...

May 14, 2014, 17:51 ET

DelMar Pharmaceuticals to Present Interim Clinical Data for Ongoing VAL-083 Glioblastoma Multiforme Trial at ASCO

DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced that the Company will present an abstract entitled, "Phase I/II study of...